Overview


According to FutureWise analysis the market for herpangina treatment in 2023 is US$ 1.68 billion, and is expected to reach US$ 2.7 billion by 2031 at a CAGR of 6.12%.

Herpangina is a viral infection that causes a high fever and blister-like sores in the mouth and throat. In daycare centers and schools where children are close to one another, the illness spreads quickly. The symptoms of herpangina are similar to those of hand, foot, and mouth disease. Children who attend daycare or school, especially those who are close to each other, are prone to contracting herpangina, a viral infection. There is a high fever and mouth sores that can be painful due to the infection. A close connection exists between herpangina and hand, foot, and mouth disease. Toddlers and children younger than 10 often suffer from herpangina, especially those who attend daycare or schools where other children interact with them. In addition to adolescents and adults, the condition is also less common in adolescents and adults. Herpangina that can be dangerous or life-threatening is more likely to occur in newborns, people with compromised immune systems, and pregnant women. Children being in close contact with each other makes herpangina a common viral infection in daycare centers and schools. Summer and fall are the most common seasons for it.

The symptoms of herpangina are blister-like sores inside the mouth and throat of your child. In severe cases, eating and drinking will be painful, and swallowing will be difficult. Despite your child's desire to avoid eating or drinking, it's important that they don't miss meals and are drinking plenty of liquids to avoid dehydration. A major driving force behind the growth of the herpangina treatment market is the rise in prevalence of the disease among the population, especially among children across the globe. With the increase in funds and awareness programs taken by private and non-private organizations, and with the advent of enhanced diagnostic techniques, the market is growing rapidly. A rise in awareness among the public about both infectious disorders caused by enteroviruses and the health of children worldwide further influences the market. In addition, pollution, healthcare expenditures, and improving healthcare infrastructure all have a positive impact on the herpangina treatment market. Market players will be able to capitalize on profitable opportunities in the forecast period due to the increase in awareness about personalized medicine.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Herpangina Treatment Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Herpangina Treatment Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

  • F.Noavrtis AG
  • Gilead Sciences Inc
  • GlaxosmithKline Plc
  • Johnson and Johnson
  • MerckCo. Inc
  • Pfizer Inc
  • AbbVie Inc
  • Vertex Pharmaceuticals Incorporated
  • ViiV Healthcare Group of Companies
  • Sanofi
  • Noavrtis AG
  • Mitsubishi Tanabe Pharma Corporation

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Virus

  • Coxsackie Virus A
  • Coxsackie Virus B
  • Enterovirus 7I
  • Echovirus

By Symptons

  • High Fever
  • Sore Throat
  • Blisters Or Ulcers In The Throat And Mouth
  • Difficulty Swallowing
  • Loss Of Appetitie
  • Headache
  • Neck Pain
  • Swollen Lymph Glands

By Treatment

  • Topical Anesthetics
  • Ibuprofen
  • Others

By End User

  • Hospitals
  • Homecare
  • Specialty
  • Clinics
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Herpangina Treatment Market By Virus, By Symptons, By Treatment, By End User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Herpangina Treatment Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Herpangina Treatment Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Herpangina Treatment Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Herpangina Treatment Market, By Virus Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Coxsackie Virus A
        2. Coxsackie Virus B
        3. Enterovirus 7I
        4. Echovirus

  • 8.   Herpangina Treatment Market, By Symptons Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. High Fever
        2. Sore Throat
        3. Blisters Or Ulcers In The Throat And Mouth
        4. Difficulty Swallowing
        5. Loss Of Appetitie
        6. Headache
        7. Neck Pain
        8. Swollen Lymph Glands

  • 9.   Herpangina Treatment Market, By Treatment Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Topical Anesthetics
        2. Ibuprofen
        3. Others

  • 10.   Herpangina Treatment Market, By End User Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Hospitals
        2. Homecare
        3. Specialty
        4. Clinics
        5. Others

  • 11.   North America Herpangina Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 12.   Latin America Herpangina Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 13.   Europe Herpangina Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 14.   Asia Pacific Herpangina Treatment Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 15.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. F.Noavrtis AG
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Gilead Sciences Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. GlaxosmithKline Plc
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Johnson & Johnson
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. MerckCo. Inc
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Pfizer Inc
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. AbbVie Inc
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Vertex Pharmaceuticals Incorporated
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. ViiV Healthcare Group of Companies
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Sanofi
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Noavrtis AG
            11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. Mitsubishi Tanabe Pharma Corporation
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 19.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients